Santiago Cavero Martínez

Santiago Cavero Martínez graduated in Biology from the Universidad Autónoma de Madrid (UAM) in 1998. His research career began with the completion of his PhD Thesis on mitochondrial transporters of the CaMC family in the yeast Saccharomyces cerevisiae (2004) at the Centro de Biología Molecular Severo Ochoa (Madrid). In 2006 he moved to the United States where he did a postdoctoral stay at The Scripps Research Institute in San Diego, studying the function of proteins involved in DNA repair mechanisms, using the yeast Schizosaccharomyces pombe as a model. Back in Spain, Santiago worked in different research institutes in Madrid, Salamanca and Barcelona, in a project aimed at generating monoclonal antibodies against mitochondrial and intermediary metabolism proteins, studying the role of histone post-translational modifications and histone variants in DNA integrity surveillance mechanisms during meiosis or investigating the response pathways to different types of stress in yeast and animal cells, among other projects.

In 2021 he joined ZeCardio Therapeutics, where he collaborated in a project in zebrafish aimed at characterizing heart disease models and identifying new drugs for their treatment.

Finally, in April 2024 Santiago joined the VIRIEVAC group led by Dr. Julia García Prado as a senior laboratory technician, where he collaborates in the different lines of research on the role of cellular immunity in the response to viral infections.